H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence

J Immunogenet. 1989 Aug-Oct;16(4-5):291-303. doi: 10.1111/j.1744-313x.1989.tb00475.x.

Abstract

The metastatic B16 mouse melanoma shows a low cell surface expression of H-2Kb and H-2Db class I antigens on cells of both the high-metastatic line B16-F10 and the low-metastatic line B16-F1. Similarly, newly generated clones of these lines, having different metastatic properties, all express low levels of major histocompatibility antigens. One of these clones, the high-metastatic F10.9, was transfected with H-2Kb genes to generate H-2Kb-expressing transfectants. The resulting clones showed reduced tumourigenicity and a low metastatic phenotype. Unlike the parental cells, H-2Kb-positive transfectants are potent inducers and sensitive targets of H-2Kb-restricted syngeneic cytotoxic T cells. Immunization of mice with H-2Kb-positive transfectants conferred protection against a subsequent challenge with Kb-positive transfectants but had only a small effect on growth and metastatic spread of parental cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Base Sequence
  • Clone Cells
  • Cytotoxicity, Immunologic
  • H-2 Antigens / genetics
  • H-2 Antigens / immunology*
  • Immunocompetence
  • Melanoma, Experimental / immunology*
  • Melanoma, Experimental / secondary
  • Mice
  • Mice, Inbred C57BL
  • Molecular Sequence Data
  • Phenotype
  • Transfection

Substances

  • H-2 Antigens